Recent studies have found that TL1A/DR3 plays an important role in many liver diseases such as non-alcoholic fatty liver disease (NAFLD) and liver fibrosis (Guo et al., 2019; Luo et al., 2021). Here, TNFSF15 is linked to metabolic dysfunction-associated steatotic liver disease.